Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition
SARS-CoV-2 억제용 항바이러스제를 탑재한 표적 나노입자 개발
Article
[키워드] ACE2
ACE2 binding site
ACE2 protein
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
anti-SARS-CoV-2
Antiviral
antiviral activity
antiviral drug
Antiviral effect
antiviral therapeutics
binding
carriers
Concentration
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
development
Effectiveness
etiological agent
evaluated
example
exhibited
host cells
identify
in viral
infected Vero E6 cells
Intervention
Ligand
ligands
mechanism
membrane
Novel coronavirus
pandemic
Perspective
pharmacological
plethora
prophylactic treatment
pulmonary tract
raised
RDV
receptor
Regulatory
Remdesivir
representing
Safe
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
significantly
Specific
specificity
Spike protein
Targeted drug delivery
Targeted nanoparticles.
targets
tested
therapy for COVID-19
translation
Vaccines
Vero E6
VERO E6 cells
viral entry
viral particle
Viral particles
would increase
[DOI] 10.1016/j.ejmech.2022.114121 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ejmech.2022.114121 PMC 바로가기 [Article Type] Article